Plasma prekallikrein/kallikrein processing by lysosomal cysteine proteases

References

Aisa, M.C., Beccari, T., Costanzi, E., and Maggio, D. (2003). Cathepsin B in osteoblasts. Biochim. Biophys. Acta1621, 149–159.10.1016/S0304-4165(03)00054-0Search in Google Scholar

Barret, A.J., Kembhavi, A.A., Brown, M.A., Kirschke, H., Knight, C.G., Tamai, M., and Hanada, K. (1982). L-trans-(epoxysuccinyl-leucylamido-4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J.201, 189–198.10.1042/bj2010189Search in Google Scholar PubMed PubMed Central

Barros, N.M.T., Tersariol, I.L., Oliva, M.L., Araujo, M.S., Sampaio, C.A.M., Juliano, L., and da Motta, G. (2004). High molecular weight kininogen as substrate for cathepsin B. Biol. Chem.385, 551–555.10.1515/BC.2004.066Search in Google Scholar PubMed

Colman, R.W., and Schmaier, A.H. (1997). Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood90, 3819–3843.10.1182/blood.V90.10.3819Search in Google Scholar

Dehrmann, F.M., Coetzer, T.H., Pike, R.N., and Dennison, C. (1995). Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. Arch. Biochem. Biophys.324, 93–98.10.1006/abbi.1995.9924Search in Google Scholar PubMed

Desmazes, C., Gauthier, F., and Lalmanach, G. (2001). Cathepsin L, but not cathepsin B, is a potential kininogenase. Biol. Chem.382, 811–815.10.1515/bchm.2001.382.5.811Search in Google Scholar

Desmazes, C., Galineau, L., Gauthier, F., Bromme, D., and Lalmanach, G. (2003). Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L. Eur. J. Biochem.270, 171–178.10.1046/j.1432-1033.2003.03382.xSearch in Google Scholar PubMed

Dickinson, D.P. (2002). Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit. Rev. Oral Biol. Med.13, 128–275.10.1177/154411130201300304Search in Google Scholar PubMed

Gillis, S., Furie, B.C., and Furie, B. (1997). Interactions of neutrophils and coagulation proteins. Semin. Hematol.34, 336–42.Search in Google Scholar

Henderson, L.M., Figueroa, C.D., Muller-Esterl, W., and Bhoola, K.D. (1994). Assembly of contact-phase factors on the surface of the human neutrophil membrane. Blood84, 474–482.10.1182/blood.V84.2.474.474Search in Google Scholar

Lecaille, F., Kaleta, J., and Brömme, D. (2002). Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem. Rev.102, 4459–4488.10.1021/cr0101656Search in Google Scholar PubMed

Linebaugh, B.E., Sameni, M., Day, N.A., Sloane, B.F., and Keppler, D. (1999). Exocytosis of active cathepsin B. Enzyme activity at pH 7.0, inhibition and molecular mass. Eur. J. Biochem.264, 100–109.Search in Google Scholar

Linke, M., Herzog, V., and Brix, K. (2002). Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal/lysosomal compartment. J. Cell Sci.115, 4877–4889.10.1242/jcs.00184Search in Google Scholar

Loza, J.P., Gurewich, V., Johnstone, M., and Pannel, R. (1994). Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. Thromb. Haemost.71, 347–352.10.1055/s-0038-1642441Search in Google Scholar

Mason, R.W. (1989). Interaction of lysosomal cysteine proteinases with α2-macroglobulin: conclusive evidence for the endopeptidase activities of cathepsins B and H. Arch. Biochem. Biophys.273, 367–374.10.1016/0003-9861(89)90495-5Search in Google Scholar

McMullen, B.A., Fujikawa, K., and Davie, E.W. (1991). Location of the disulfide bonds in human plasma prekallikrein: the presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry30, 2050–2056.10.1021/bi00222a007Search in Google Scholar

Mort, J.S., and Buttle, D.J. (1997). Cathepsin B. Int. J. Biochem. Cell. Biol.29, 715–720.10.1016/S1357-2725(96)00152-5Search in Google Scholar

Motta, G., Sampaio, M.U., and Sampaio, C.A.M. (1989). Hydrolysis of synthetic peptides and natural substrates by plasma kallikrein and its light chain. Adv. Exp. Med. Biol.247B, 239–242.10.1007/978-1-4615-9546-5_39Search in Google Scholar PubMed

Motta, G., Fink, E., Sampaio, M.U., and Sampaio, C.A.M. (1992). Human plasma kallikrein processing: proteolysis as an alternative control. Agents Actions38 (Suppl.), 265–277.Search in Google Scholar

Motta, G., Rojkjaer, R., Hasan, A.A.K., Cines, D.B., and Schmaier A.H. (1998). High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood91, 516–528.10.1182/blood.V91.2.516Search in Google Scholar

Motta, G., Shariat-Madar, Z., Mahdi, F., Sampaio, C.A.M., and Schmaier, A.H. (2001). Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix. Thromb. Haemost.86, 840–847.Search in Google Scholar

Nagaoka, M.R., Strital, E., Kouyoumdjian, M., and Borges, D.R. (2003). Participation of a galectin-dependent mechanism in the hepatic clearance of tissue-type plasminogen activator and plasma kallikrein. Thromb. Res.108, 257–262.Search in Google Scholar

Nagase, H., and Barret, A.J. (1981). Human plasma kallikrein. A rapid purification method with high yield. Biochem J.193, 187–192.Search in Google Scholar

Nägler, D.K., Storer, A.C., Portaro, F.C.V., Carmona, E., Juliano, L., and Ménard, R. (1997). Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry36, 12608–12615.10.1021/bi971264+Search in Google Scholar PubMed

Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A.Y. (1998). Cathepsin L: critical role in li degradation and CD4 T cell selection in the thymus. Science280, 450–453.10.1126/science.280.5362.450Search in Google Scholar PubMed

Neth, P., Arnhold, M., Nitschko, H., and Fink, E. (2001). The mRNAs of prekallikrein, factors XI and XII, and kininogen, components of the contact phase cascade are differentially expressed in multiple non-hepatic human tissues. Thromb. Haemost.85, 1043–1047.10.1055/s-0037-1615961Search in Google Scholar

Oliva, M.L.V., Sampaio, M.U., and Sampaio, C.A.M. (1982). Properties of highly purified human plasma kallikrein. Agents Actions9, 52–57.Search in Google Scholar

Owen, C.A., and Campbell, E.J. (1999). The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol.65, 137–150.10.1002/jlb.65.2.137Search in Google Scholar

Reddy, V.Y., Zhang, Q.Y., and Weiss, S.J. (1995). Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA92, 3849–3853.10.1073/pnas.92.9.3849Search in Google Scholar

Renné, T., Dedio, J., Meijers, J.C., Chung, D., and Müller-Esterl, W. (1999). Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2. J. Biol. Chem.274, 25777–25784.10.1074/jbc.274.36.25777Search in Google Scholar

Rifkin, B.R., Vernillo, A.T., Kleckner, A.P., Auszmann, J.M., Rosenberg, L.R., and Zimmerman, M. (1991). Cathepsin B and L activities in isolated osteoclasts. Biochem. Biophys. Res. Commun.179, 63–69.10.1016/0006-291X(91)91334-9Search in Google Scholar

Roth, W., Deussing, J., Botchkarev, V.A., Pauly-Evers, M., Saftig, P., Hafner, A., Schmidt, P., Schmahl, W., Scherer, J., Anton-Lamprecht, I., et al. (2000). Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J.14, 2075–86.10.1096/fj.99-0970comSearch in Google Scholar PubMed

Schapira, M., Scott, C.F., James, A., Silver, L.D., Kueppers, F., James, H.L., and Colman, R.W. (1982). High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. Biochemistry21, 567–572.10.1021/bi00532a024Search in Google Scholar PubMed

Schmaier, A.H. (2003). The kallikrein-kinin and renin-angiotensin systems have a multilayered interaction. Am. J. Physiol. Regul. Integr. Comp. Physiol.285, R1–R13.10.1152/ajpregu.00535.2002Search in Google Scholar PubMed

Staquicini, F.I., Moreira, C.R., Nascimento, F.D., Tersariol, I.L., Nader, H.B., Dietrich, C.P., and Lopes, J.D. (2003). Enzyme and integrin expression by high and low metastatic melanoma cell lines. Melanoma Res.13, 11–18.10.1097/00008390-200302000-00003Search in Google Scholar PubMed

Wiederanders, B., Kaulmann, G., and Schilling, K. (2003). Functions of propeptide parts in cysteine proteases. Curr. Protein Peptide Sci.4, 309–326.10.2174/1389203033487081Search in Google Scholar PubMed

Xing, R., Addington, A.K., and Mason, R.W. (1998). Quantification of cathepsins B and L in cells. Biochem J.332, 499–505.10.1042/bj3320499Search in Google Scholar PubMed PubMed Central

Yu, H., Anderson, P.J., Freedman, B.I., Rich, S.S., and Bowden, D.W. (2000). Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. Genomics69, 225–234.10.1006/geno.2000.6330Search in Google Scholar PubMed